Living with bone metastases often means dealing with persistent, intense pain. While standard radiation (cEBRT) is a common way to manage these symptoms, a new review of clinical data suggests that a more targeted approach called SBRT might offer better long-term results for some patients.
Researchers compared SBRT to traditional radiation and found that while both methods were equally effective at reducing pain within the first three months, SBRT performed better over time. Specifically, patients receiving SBRT had significantly higher rates of complete pain relief at six months and much lower rates of worsening pain. The study also showed that SBRT led to better local tumor control and a much lower need for repeat radiation treatments.
Both methods were found to be safe and equally effective at reducing opioid use. However, the choice between them may depend on a patient's specific situation. SBRT may be especially helpful for those with a longer life expectancy or high-risk tumors, while standard radiation remains a reliable way to quickly manage symptoms for those needing fast relief.
